Peritoneal Metastases clinical trials

Explore recruiting peritoneal metastases clinical trials.

Recruiting peritoneal metastases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peritoneal Metastases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INTERACT-FAPI: “The value of 68Ga-FAPI PET/CT for evaluating peritoneal treatment response.”

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for resectable colorectal peritoneal metastases: a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).

Belgium, Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET)

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Intraperitoneal irinotecan combined with systemic therapy for patients with gastric peritoneal metastases: A phase II, multicenter study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Normothermic intraperitoneal chemotherapy – long term in peritoneal metastases from colorectal cancer – feasibility study

Norway

Human Pharmacology (Phase I)- Other EU CTIS Study details

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases. A single-arm, open-label, phase II trial. Nab-PIPAC Trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Peritoneal Metastases trials by city

Peritoneal Metastases in Toronto Peritoneal Metastases in Vancouver Peritoneal Metastases in Montreal Peritoneal Metastases in Calgary Peritoneal Metastases in Edmonton Peritoneal Metastases in Ottawa Peritoneal Metastases in Winnipeg Peritoneal Metastases in Quebec City Peritoneal Metastases in Hamilton Peritoneal Metastases in Kitchener Peritoneal Metastases in London Peritoneal Metastases in Halifax Peritoneal Metastases in New York Peritoneal Metastases in Los Angeles Peritoneal Metastases in Chicago Peritoneal Metastases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease